发明名称 composto 2,4-diaminopirimidina
摘要 [Problem] Provided is a compound which is useful as an active ingredient for a pharmaceutical having a PKC¸ inhibition activity, particularly a pharmaceutical composition for inhibiting acute rejection occurring in transplantation. [Means for Solution] The present inventors have conducted extensive studies on a compound having a PKC¸ inhibition activity, and as a result, they have found that a compound having a structure such as aralkyl and the like on an amino group at the 2-position and also having a structure such as an adamantylalkyl group and the like on an amino group at the 4-position of 2,4-diaminopyrimidine, or a salt thereof has an excellent PKC¸ inhibition activity, thereby completing the present invention. The 2,4-diaminopyrimidine compound of the present invention can be used as a PKC¸ inhibitor or an inhibitor of acute rejection occurring in transplantation.
申请公布号 BRPI0918472(A2) 申请公布日期 2015.12.01
申请号 BR2009PI18472 申请日期 2009.08.31
申请人 ASTELLAS PHARMA INC 发明人 AKIRA TANAKA;JUN MAEDA;KOICHIRO MUKOYOSHI;NOBORU CHIDA;SHIGEKI KUNIKAWA;SHINYA NAGASHIMA;YUJI TAKASUNA
分类号 A61K31/505;A61K31/506;A61K31/5377;A61K31/5513;A61P37/06;C07D239/48;C07D401/12;C07D403/12;C07D405/12;C07D405/14;C07D409/12;C07D453/02;C07D471/08 主分类号 A61K31/505
代理机构 代理人
主权项
地址